EST
AHCO icon

EA Series Trust’s AdaptHealth AHCO Stock Holding History

EA Series Trust’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$4.73M Buy
+388,669
New +$4.33M 0.17% 145

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EA Series Trust's AHCO Position: Q2 2023 in Review

EA Series Trust opened a new position in AdaptHealth (AHCO) in Q2 2023: 388,669 shares worth $4.73M. The stake represents 0.17% of the portfolio and ranks #145 among its holdings.

182 funds tracked by Wall St. Rank hold AHCO as of Q2 2023.

  • EA Series Trust held 388,669 shares of AdaptHealth worth $4.73M as of Q2 2023.
  • AdaptHealth was a new EA Series Trust position in Q2 2023.
  • AdaptHealth made up 0.17% of EA Series Trust's portfolio in Q2 2023, its #145 holding.
  • 182 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.